References
- 1. Chawla G, Ranjan C, Kumar J, Siddiqui AA. Chemical modifications of ketoprofen (NSAID) in search of better lead compounds: A Review of literature from 2004-2016. Antiinflamm Antiallergy Agents Med Chem. 2017;15(3):154-77.
- 2. Kuczyńska J, Nieradko-Iwanicka B. Future prospects of ketoprofen in improving the safety of the gastric mucosa. Biomed Pharmacother. 2021;139:111608.
- 3. Patrignani P, Patrono C. Cyclooxygenase inhibitors: From pharmacology to clinical read-outs. Biochim Biophys Acta. 2015; 1851(4):422-32.
- 4. Kayipmaz AE, Giray TA, Tasci SS, Tasci SS, Kavalci C, Kocalar UG. Acute dystonic reaction due to dexketoprofen trometamol. J Pak Med Assoc. 2015;65(11):1231-2.
- 5. Kuczyńska J, Nieradko-Iwanicka B. The effect of ketoprofen lysine salt on mucosa of rat stomach after ethyl alcohol intoxication. Biomed Pharmacother. 2021;141:111938.
- 6. Cheng YT, Lin JA, Jhang JJ, Yen GC. Protocatechuic acid-mediated DJ-1/PARK7 activation followed by PI3K/mTOR signaling pathway activation as a novel mechanism for protection against ketoprofen-induced oxidative damage in the gastrointestinal mucosa. Free Radic Biol Med. 2019;130:35-47.
- 7. Pereira-Leite C, Nunes C, Jamal SK, Cuccovia IM, Reis S. Nonsteroidal anti-inflammatory therapy: A journey toward safety. Med Res Rev. 2017;37(4):802-59.
- 8. Wang J, Zhao SQ, Zhang MY, He BS. Targeted ecopharmacovigilance for ketoprofen in the environment: Need, strategy and challenge. Chemosphere. 2018;194:450-462.
- 9. Rafanan BS Jr, Valdecañas BF, Lim BP, Malairungsakul A, Tassanawipas W, Shiyi C, et al. Consensus recommendations for managing osteoarthritic pain with topical NSAIDs in Asia-Pacific. Pain Manag. 2018;8(2):115-28.
- 10. Ketoprofen, Summary of Product Characteristics. [https://bazalekow.mp.pl/leki/doctor_subst.html?id=444] (accessed 19 March 2022).
- 11. Cerciello A, Auriemma G, Del Gaudio P, Cantarini M, Aquino RP. Natural polysaccharides platforms for oral controlled release of ketoprofen lysine salt. Drug Dev Ind Pharm. 2016;42(12):2063-9.
- 12. Cimini A, Brandolini L, Gentile R, Cristiano L, Menghini P, Fidoamore A, et al. Gastroprotective effects of L-lysine salification of ketoprofen in ethanol-injured gastric mucosa. J Cell Physiol. 2015; 230(4):813-20.
- 13. Brandolini L, d’Angelo M, Antonosante A, Villa S, Cristiano L, Castelli V, et al. Differential protein modulation by ketoprofen and ibuprofen underlines different cellular response by gastric epithelium. J Cell Physiol. 2018;233(3):2304-12.
- 14. Gemici B, Elsheikh W, Feitosa KB, Costa SK, Muscara MN, Wallace JL. H2S-releasing drugs: Anti-inflammatory, cytoprotective and chemopreventative potential. Nitric Oxide. 2015;46:25-31.
- 15. Seuanes GC, Moreira MB, Petta T, de Moraes Del Lama MPF, de Moraes LAB, de Oliveira ARM, et al. Novel binuclear μ-oxo diruthenium complexes combined with ibuprofen and ketoprofen: Interaction with relevant target biomolecules and anti-allergic potential. J Inorg Biochem. 2015;153:178-85.
- 16. Wang Z, Ma C, Shang Y, Yang L, Zhang J, Yang C, et al. Simultaneous co-assembly of fenofibrate and ketoprofen peptide for the dual-targeted treatment of nonalcoholic fatty liver disease (NAFLD). Chem Commun (Camb). 2020;56(36):4922-5.
- 17. Tian W, Rockson SG, Jiang X, Kim J, Begaye A, Shuffle EM, et al. Leukotriene B4 antagonism ameliorates experimental lymphedema. Sci Transl Med. 2017;9(389):eaal3920.
- 18. Rockson SG, Tian W, Jiang X, Kuznetsova T, Haddad F, Zampell J, et al. Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema. JCI Insight. 2018; 3(20):e123775.
- 19. Erbaş O, Solmaz V, Aksoy D. Inhibitor effect of dexketoprofen in rat model of pentylenetetrazol-induced seizures. Neurol Res. 2015;37(12): 1096-101.
- 20. Makunts T, Cohen IV, Lee KC, Abagyan R. Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain. PLoS One. 2018;13(4):e0195521.
- 21. Ravera M, Zanellato I, Gabano E, Perin E, Rangone B, Coppola M, et al. Antiproliferative activity of Pt(IV) conjugates containing the non-steroidal anti-inflammatory drugs (NSAIDs) ketoprofen and Nnproxen. Int J Mol Sci. 2019;20(12):3074.
- 22. Yu T, Lao X, Zheng H. Influencing COX-2 Activity by COX related pathways in inflammation and cancer. Mini Rev Med Chem. 2016; 16(15):1230-43.
- 23. Çoban Ö, Değim Z, Yılmaz Ş, Altıntaş L, Arsoy T, Sözmen M. Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma. Drug Dev Res. 2019;80(5):556-65.
- 24. Ferreira LM, Cervi VF, Gehrcke M, da Silveira EF, Azambuja JH, Braganhol E, et al. Ketoprofen-loaded pomegranate seed oil nanoemulsion stabilized by pullulan: Selective antiglioma formulation for intravenous administration. Colloids Surf B Biointerfaces. 2015;130:272-7.
- 25. Noverraz F, Montanari E, Pimenta J, Szabó L, Ortiz D, Gonelle-Gispert C, et al. Antifibrotic effect of ketoprofen-grafted alginate microcapsules in the transplantation of insulin producing cells. Bioconjug Chem. 2018;29(6):1932-41.